Hypertension,Essential
62
10
12
34
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.6%
1 terminated out of 62 trials
97.1%
+10.6% vs benchmark
15%
9 trials in Phase 3/4
9%
3 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (62)
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects
Engaging Home-monitored Assessment to Navigate Clinical Decision-making
Mobile Health Program for Rural Hypertension
The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Implementing Hypertension Screening Guidelines in Primary Care
The TARGET BP OFF-MED Trial
A Study to Evaluate the Efficacy and Safety of AD-223
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
A Study to Evaluate the Efficacy and Safety of AD-224
Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia
Licorice and Home Blood Pressure, Additional Study
Long-term Use of CCB and Breast Cancer Risk
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension